CDK5 serves as a major control point in neurotransmitter release. [electronic resource]
Producer: 20101001Description: 797-809 p. digitalISSN:- 1097-4199
- 6-Cyano-7-nitroquinoxaline-2,3-dione -- pharmacology
- Animals
- Animals, Newborn
- Cyclin-Dependent Kinase 5 -- antagonists & inhibitors
- Electric Stimulation -- methods
- Excitatory Amino Acid Antagonists -- pharmacology
- Gene Expression Regulation -- drug effects
- Green Fluorescent Proteins -- genetics
- Hippocampus -- cytology
- In Vitro Techniques
- Munc18 Proteins -- metabolism
- Neurons -- drug effects
- Neurotransmitter Agents -- metabolism
- Protein Kinase Inhibitors -- pharmacology
- Purines -- pharmacology
- RNA, Small Interfering -- genetics
- Rats
- Rats, Sprague-Dawley
- Roscovitine
- Sodium Channel Blockers -- pharmacology
- Synapses -- drug effects
- Tetrodotoxin -- pharmacology
- Transfection -- methods
- Valine -- analogs & derivatives
- Vesicle-Associated Membrane Protein 2 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.